臨床薬理
Online ISSN : 1882-8272
Print ISSN : 0388-1601
新抗うつ薬ZimelidineとImipramineの生理学的指標に及ぼす影響の比較
岸本 朗小椋 力水川 六郎筒井 俊夫小村 文明松林 実田村 辰祥挾間 秀文
著者情報
ジャーナル フリー

14 巻 (1983) 2 号 p. 387-398

詳細
PDFをダウンロード (1585K) 発行機関連絡先
抄録

To compare adverse reactions due to zimelidine (ZMD) and imipramine (IMP), double blind control trials were performed in healthy young (mean age: 23.4 years) male volunteers.
Influence on self-ratings and physiological measurements were compared in cross-over fashion between a single oral administration of ZMD 50 mg and that of IMP 25 mg, and ZMD 100 mg and IMP 50 mg, respectively.
ZMD hardly changed heart rate, but IMP 50 mg induced tachycardia 3 to 24 hrs after the administration. ZMD did not influence systolic blood pressure. On the other hand, IMP 50 mg decreased systolic blood pressure and there was a significant difference between the two drugs 4 hrs after the administration (p<0.05). Postual hypotention was recognized in the case of IMP administration.
ZMD 100mg decreased critical fusion frequency of flicker less than IMP 50mg (p<0.05-0.01).
ZMD did not influence salivary rate, but after IMP 25 mg or 50 mg of IMP intense decrease of salivary rate was observed.
There were no significant differences after the two drugs in the measurements of function of equibrium, tapping rate, accomodation width and standing ability on one foot.

著者関連情報
© 日本臨床薬理学会
前の記事 次の記事

閲覧履歴
feedback
Top